Randomized Phase 2 Trial of Stereotactic Body Radiation Therapy (SBRT) and Concurrent and Adjuvant Cetuximab vs Cetuximab and Docetaxel in Recurrent, Previously Irradiated Squamous Cell Carcinoma of the Head and Neck

Autor: Wilke, C.T., Ferris, R.L., Ohr, J., Zandberg, D.P., Rahman, Z., Kim, S., Snyderman, C., Johnson, J.T., Burton, S.A., Olson, A.C., Petro, D., Marks, S., Francis, L., Friedland, D., Gorantla, V., Mountz, J., Wang, H., Heron, D.E., Clump, D.A., II, Skinner, H.D.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e43-e44
Databáze: ScienceDirect